Related Experiment Video
Updated: May 27, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Preferences for longer acting pre-exposure prophylaxis in transgender and gender expansive texans: centering gender
Julie A Zuñiga1, Julie E Mellin1, Gabrielle Benitez2
1School of Nursing, The University of Texas at Austin, Austin, TX, USA.
Abstract:
The prevalence of HIV is higher in the transgender population than in the general population, and pre-exposure prophylaxis (PrEP) is an effective biomedical HIV prevention strategy for the prevention of HIV. However, the transgender and gender-expansive community faces several challenges to PrEP uptake and adherence. This community-based participatory study was conducted to understand preferences for long-acting PrEP modalities better. Data were collected virtually with an adapted version of the World Café Conversation method and in-depth interviews. A total of 33 transgender and gender-diverse individuals participated in either a World Café conversation or an individual interview about preferences for long-acting PrEP. All qualitative data were transcribed and coded for themes. Two themes emerged: (1) challenges related to long-acting PrEP for transgender and gender-expansive individuals and (2) bundling long-acting PrEP and gender-affirming hormone therapy. To improve access and adherence, HIV prevention needs to be included as part of gender-affirming hormone therapy to align with patients' health priorities.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Birth Control Methods
Drug Therapy
Antianxiety Medications
Desensitization and Tachyphylaxis
Signs of Puberty
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...

